The goal of this clinical trial is to compare the efficacy of L-ornithine L-aspartate and Polyethylene Glycol in Cirrhotic Patients with Overt Hepatic Encephalopathy. Participants will be asked to fill out a few questions on proforma that will obtain demographic information as well as information relating to the patient's health. Treatments that they will receive after inclusion in the study, will be the standard treatment (Lactulose) along with additional medication as part of our research (LOLA or Polyethylene glycol).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Patient recovery among all groups through a change in mental state.
Timeframe: Change will be assessed at enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: Change will be assessed at 24 hours post enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: A change will be assessed at 48 hours post enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: A change will be assessed at 72 hours post enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: A change will be assessed at 96 hours post enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: A change will be assessed at 120 hours post enrollment.
Patient recovery among all groups through a change in mental state.
Timeframe: A change will be assessed at 144 hours post enrollment.